2025-12-19T13:10:01-06:00 2025-06-30 930900579 MCDONALD JACOBS PC 121 SW SALMON ST STE 1100 PORTLAND OR 97204 990 2024-07-01 930571472 NATIONAL PSORIASIS FOUNDATION NATI 5032447404 1800 DIAGONAL ROAD 360 ALEXANDRIA VA 22314 RONALD GOLDSMAN CHIEF FINANCIAL OFFICER 5032447404 2025-12-18 1 1 SANG AHN P00540880 5032270581 2024 2025-03-06 01:10:19Z LEAH MCCORMICK HOWARD 1800 DIAGONAL ROAD 360 ALEXANDRIA VA 22314 14318314 0 X WWW.PSORIASIS.ORG X 1968 VA TO DRIVE EFFORTS TO CURE PSORIATIC DISEASE AND IMPROVE THE LIVES OF THOSE AFFECTED. 19 19 57 624 1007127 335905 10084711 10587360 1933982 2021113 207360 721070 -630285 -681062 11595768 12648481 2930843 2513494 0 0 6312918 6109248 233613 0 1208828 3109478 3115220 12586852 11737962 -991084 910519 14679906 14911131 5940214 4949799 8739692 9961332 X THE NATIONAL PSORIASIS FOUNDATION PROVIDES PEOPLE WITH PSORIASIS AND PSORIATIC ARTHRITIS THE SERVICES THEY NEED TO BEST MANAGE THEIR CONDITION, WHILE PROMOTING RESEARCH TO FIND A CURE. 0 0 3442648 2513494 RESEARCHTHE NATIONAL PSORIASIS FOUNDATION (NPF) CONTINUES TO BE A LEADER IN FUNDING AND DRIVING RESEARCH TO CURE PSORIATIC DISEASE. IN FY 2025, NPF INVESTED OVER $2.5M IN RESEARCH GRANTS AND FELLOWSHIP AWARDS TOWARDS OUTSIDE-THE-BOX IDEAS AND SUPPORTED YOUNG RESEARCHERS, ENSURING PROGRESS TOWARD NOVEL TREATMENTS. THROUGH PARTNERSHIPS SUCH AS THE ACCELERATED MEDICINES PARTNERSHIP FOR AUTOIMMUNE AND IMMUNE-MEDIATED DISEASES (AMP AIM), NPF HAS WORKED WITH INDUSTRY AND NONPROFIT STAKEHOLDERS TO IDENTIFY MOLECULAR PATHWAYS AND ACCELERATE TREATMENT DEVELOPMENT. BRIDGE GRANTS HAVE ENABLED NEAR-MISS NIH RESEARCH APPLICATIONS TO SECURE ADDITIONAL DATA AND EVENTUALLY OBTAIN FEDERAL FUNDING, MULTIPLYING DONOR INVESTMENT MANY TIMES OVER. OVER THE LIFETIME OF THIS GRANT OFFERING, EVERY BRIDGE GRANT RECIPIENT SUCCESSFULLY OBTAINED FURTHER FUNDING AFTER RESUBMISSION, TURNING $1.5 MILLION IN NPF GRANTS INTO $13.5 MILLION IN FEDERAL SUPPORT. NPF COLLABORATED WITH THE GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES AND COMMUNITY ORGANIZATIONS TO EXPAND ACCESS TO DERMATOLOGIC CARE IN UNDERSERVED WASHINGTON, D.C. NEIGHBORHOODS. QUALITATIVE RESEARCH, SUCH AS THE S.T.R.A.N.D. INITIATIVE, EDUCATED HAIR STYLISTS ON RECOGNIZING SCALP CONDITIONS, BROADENING COMMUNITY AWARENESS AND EARLY DETECTION. THE NPF HEALTH CARE PROVIDER DIRECTORY WAS ENHANCED IN 2025 BY REQUIRING PROVIDERS TO ATTEST TO DELIVERING GUIDELINE-BASED, HIGH-QUALITY CARE FOCUSED ON MINIMAL DISEASE ACTIVITY AND CONTINUOUS PROFESSIONAL GROWTH. 1318997 12000 PROFESSIONAL EDUCATIONNPF CONTINUED TO EXPAND AND STRENGTHEN MEDICAL EDUCATION PROGRAMMING TARGETING HEALTH CARE PROVIDERS AT ALL LEVELS AND STAGES OF CAREER. THE 26TH ANNUAL RESIDENTS AND RHEUMATOLOGY FELLOWS MEETING OFFERED DERMATOLOGY RESIDENTS AND RHEUMATOLOGY FELLOWS THE LATEST IN PSORIATIC DISEASE TREATMENT PRESENTED BY EXPERTS IN THE FIELD. THROUGH ITS DEDICATION TO EDUCATING HEALTH CARE PROVIDERS ON PSORIATIC DISEASE AND ITS RELATED DISEASES, NPF HAS EARNED ACCREDITATION AS A PROVIDER OF CONTINUING MEDICAL EDUCATION. IT'S PART OF OUR EFFORTS TO ENSURE ALL DIFFERENT TYPES OF HEALTH CARE PROVIDERS UNDERSTAND THIS COMPLICATED DISEASE. NPF OFFERS THE PSOUND BYTES CONTINUING MEDICAL EDUCATION PODCASTS, WEBINARS, AND IN-PERSON CLASSES AND SEMINARS FOR A WIDE RANGE OF AUDIENCES. IN FY 2025, THE NPF CELEBRATED THE INDEXING OF THE JOURNAL OF PSORIASIS AND PSORIATIC ARTHRITIS, A PEER REVIEWED OUTLET FEATURING CME ARTICLES, ALLOWING MANY MORE RESEARCHERS, CLINICIANS, AND PATIENTS TO ACCESS VALUABLE INFORMATION IN EACH ARTICLE. 1211482 ADVOCACYNPF FURTHER AMPLIFIED ITS ADVOCACY EFFORTS. THE ORGANIZATION CONTINUES TO CHAMPION PATIENT-FRIENDLY LEGISLATION, NOTABLY THE SAFE STEP ACT, AND HAS SUPPORTED STEP THERAPY REFORMS AND COPAY ACCUMULATOR PROTECTIONS ACROSS 40 STATES. NPF REGULARLY ADVOCATES ON CAPITOL HILL FOR BETTER CARE, ACCESS, AND FAIR PRICING. IN FY 2025, NPF PROACTIVELY EDUCATED ITS COMMUNITY ABOUT SIGNIFICANT MEDICARE CHANGES THROUGH ARTICLES, PODCASTS, AND WEBINARS, HELPING PATIENTS NAVIGATE NEW OUT-OF-POCKET MAXIMUMS AND PRESCRIPTION OPTIONS. 3260312 1001986 EDUCATION, OUTREACH, AND PATIENT SERVICESNPF'S PUBLIC RELATIONS AND EDUCATION CAMPAIGNS REACHED BROAD AUDIENCES, FEATURING DYNAMIC CONTENT TO REDUCE STIGMA AND DRIVE AWARENESS. THE #THISISPSORIASIS CAMPAIGN UTILIZED MEDIA TOURS AND VIDEOS FROM COMMUNITY MEMBERS TO DEBUNK MYTHS AND FOSTER UNDERSTANDING. NPF ALSO LAUNCHED IMPACTFUL CAMPAIGNS FOR RARE FORMS OF THE DISEASE, SUCH AS GENERALIZED PUSTULAR PSORIASIS (GPP), EDUCATING PATIENTS AND PROVIDERS TO SAVE LIVES THROUGH TIMELY DIAGNOSIS AND INTERVENTION. NPF OPTIMIZED ITS DIGITAL PRESENCE, MAKING PSORIASIS.ORG A TRUSTED RESOURCE FOR OVER 4 MILLION ANNUAL VISITORS. EFFORTS INCLUDED THE LAUNCH OF THE RESOURCE LIBRARY AND THE MONTHLY PSORIASIS INSIDER NEWSLETTER, SIGNIFICANTLY INCREASING ACCESS TO RELIABLE INFORMATION FOR BOTH PATIENTS AND PROVIDERS. SINCE 2016, NPF'S PATIENT NAVIGATION CENTER HAS SUPPORTED OVER 90,000 PATIENTS AND THEIR CAREGIVERS WITH FREE, PERSONALIZED SUPPORT DESIGNED TO HELP THEM UNDERSTAND PSORIATIC DISEASE AND TREATMENT OPTIONS, NAVIGATE INSURANCE CHALLENGES, AND FIND THE APPROPRIATE HEALTH CARE PROVIDER. 3260312 1001986 9233439 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 86 0 57 1 1 1 0 0 0 0 1 1 0 0 0 0 0 0 X 19 19 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X RONALD GOLDSMAN 5032447404 1800 DIAGONAL ROAD 360 ALEXANDRIA VA 22314 CAROL OSTROW CHAIR 1.00 X X 0 0 0 EYAL OFIR VICE CHAIR 1.00 X X 0 0 0 MARY CARROLL SECRETARY 1.00 X X 0 0 0 BRIAN JANSSEN TREASURER 1.00 X X 0 0 0 ANDY BLAUVELT MD MEDICAL BOARD CHAIR 1.00 X X 0 0 0 RON GRAU PAST CHAIR 1.00 X X 0 0 0 KEN ANSIN DIRECTOR 1.00 X 0 0 0 KELLI AMERINE DIRECTOR 1.00 X 0 0 0 DIANA SANDLER MD DIRECTOR 1.00 X 0 0 0 CHRISTINE LINDSAY DIRECTOR 1.00 X 0 0 0 LARRY GREEN MD DIRECTOR 1.00 X 0 0 0 MICHAEL GRAFF DIRECTOR 1.00 X 0 0 0 ELAINE HUSNI MD DIRECTOR 1.00 X 0 0 0 VALERIE HARRISON DIRECTOR 1.00 X 0 0 0 KATHLEEN GALLANT DIRECTOR 1.00 X 0 0 0 JONATHAN SCOTT DIRECTOR 1.00 X 0 0 0 NICOLE KUBIN FROM MAY 2025 DIRECTOR 1.00 X 0 0 0 LEON KIRCIK MD FROM MAY 2025 DIRECTOR 1.00 X 0 0 0 KEITH GRAFF FROM MAY 2025 DIRECTOR 1.00 X 0 0 0 LEAH MCCORMICK HOWARD PRESIDENT/CEO 40.00 X 399224 0 43603 RONALD GOLDSMAN CHIEF FINANCIAL OFFICER 40.00 X 226395 0 20625 JENNIFER FAGERSTROM CHIEF REVENUE OFFICER 40.00 X 231654 0 47071 GUY EAKIN CHIEF SCIENTIFC & MEDICAL OFFICER 40.00 X 254350 0 33812 JASON HARRIS VICE PRESIDENT OF GOVERNMENT RELATIONS & ADVOCACY 40.00 X 158156 0 18207 BREANNA BAER VICE PRESIDENT, FIELD DEVELOPMENT & OPERATIONS 40.00 X 149303 0 24983 JENNIFER O'CONNOR VICE PRESIDENT OF ADVANCEMENT 40.00 X 160412 0 22921 KATHERINE SOUTHWICK VICE PRESIDENT OF MARKETING & COMMUNICATIONS 40.00 X 144256 0 17388 1723750 0 228610 9 0 1 0 RATIONAL 360 INC 1828 L ST NW SUITE 640 WASHINGTON DC 20036 DIRECT MARKETING AGENCY 137000 BRG COMMUNICATIONS INC 201 N UNION STREET SUITE 110 ALEXANDRIA VA 22314 PUBLIC RELATIONS 106500 2 23777 3371982 399409 6792192 195719 10587360 ADVERTISING INCOME 541800 1007127 1007127 PRODUCT CERTIFICATION 541900 572660 572660 PATIENT RECRUITMENT 541900 377013 377013 ROYALTIES 541900 34213 34213 SCIENTIFIC ADVISORY 541900 12000 12000 18100 18100 2021113 302841 302841 1307000 100000 888771 100000 418229 0 418229 418229 0 3371982 681062 -681062 -681062 12648481 1013986 1007127 40008 1988594 1988594 524900 524900 1192804 860305 201982 130517 4004877 2888506 678152 438219 78569 56668 13303 8598 466956 336792 79069 51095 366042 264007 61982 40053 40750 31082 5873 3795 27500 19834 4657 3009 12000 12000 32387 32387 1081114 1005132 18942 57040 183247 173861 9386 103271 56580 11749 34942 119168 85949 20179 13040 293315 190221 4490 98604 346548 255302 6178 85068 57286 41318 9700 6268 57462 41444 9730 6288 DUES AND SUBSCRIPTIONS 391574 288689 25751 77134 PRINTING AND POSTAGE 186860 91155 648 95057 TAXES 90165 90165 BANK & CREDIT CARD FEES 65228 19987 45241 27345 21100 771 5474 11737962 9233439 1295695 1208828 X 1023562 2078135 2461795 1967567 443481 639249 2630 1938 226382 182488 367601 249137 223877 118464 9620108 9324619 678071 598671 14679906 14911131 952666 914426 4024290 2986466 121375 187732 841883 861175 5940214 4949799 X 5271417 6032984 3468275 3928348 8739692 9961332 14679906 14911131 X 910519 350176 -39055 X X 0 1 X 1 0 X 11146561 11642853 9711727 10084711 10587360 53173212 11146561 11642853 9711727 10084711 10587360 53173212 15037825 38135387 164668 214822 284300 318102 302841 1284733 1065032 185995 311307 397931 374228 2334493 56792438 3698217 0.67150 0.62010 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 48856 142337 191193 10305554 10496747 674837 168709 0 0 711018 763609 704988 674837 2854452 4281678 153665 229678 245323 191193 819859 177755 190902 176247 168709 713613 1070420 69888 79586 49093 48856 247423 SCHEDULE C, PART II-A, LINE 1 OUR ADVOCACY TEAM IS LED BY GOVERNMENT RELATIONS EXPERTS THAT TRACK AND IDENTIFY STATE AND FEDERAL OPPORTUNITIES TO SPEAK UP ON BEHALF OF THE OVER 8 MILLION AMERICANS LIVING WITH PSORIATIC DISEASE. WE DEVELOP POSITION STATEMENTS THAT OUR STAFF AND VOLUNTEERS CAN TAKE INTO MEETINGS WITH POLICYMAKERS. WE WORK WITH VARIOUS STAKEHOLDERS, INCLUDING GOVERNMENT OFFICIALS, INSURERS, PHARMACY BENEFIT MANAGERS, PHARMACEUTICAL MANUFACTURERS, AND EMPLOYERS, TO SPREAD AWARENESS ABOUT THE DAY-TO-DAY CHALLENGES OF LIVING WITH PSORIATIC DISEASE AND ADVOCATE ON BEHALF OF POLICY CHANGES THAT ELIMINATE ACCESS TO CARE BARRIERS. EACH YEAR, THE FOUNDATION HOLDS A CAPITOL HILL DAY TO ADVOCATE FOR POLICIES THAT IMPROVE ACCESS TO CARE. 18000 900 17100 135571 79358 56213 214030 168879 45151 118464 DEFERRED COMPENSATION PLAN 101589 OPERATING LEASE 759586 861175 X 12972140 350176 500 5370 356046 12616094 32387 32387 12648481 11750500 500 58827 59327 11691173 32387 14402 46789 11737962 PART X, LINE 2: THE ORGANIZATION FOLLOWS THE PROVISION OF FASB ASC TOPIC 740 OF ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. MANAGEMENT HAS EVALUATED THE ORGANIZATION'S TAX POSITIONS AND CONCLUDED THAT THERE ARE NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE FINANCIAL STATEMENTS TO COMPLY WITH PROVISIONS OF THIS TOPIC. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN GIFT ANNUITY VALUATION 5,370. PART XII, LINE 2D - OTHER ADJUSTMENTS: LOSS FROM UNCOLLECTIBLES INCLUDED AS A CHANGE IN NET ASSETS ON FORM 990 58,827. PART XII, LINE 4B - OTHER ADJUSTMENTS: GRANT TURNBACKS NETTED WITH EXPENSES ON FINANCIAL STATEMENTS 14,402. 1 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANT EXPENSES PSORIATIC DISEASE RESEARCH FELLOWSHIP GRANT 50000 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 GRANT EXPENSES TRANSLATIONAL RESEARCH GRANT AND DISCOVERY GRANT 275000 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 GRANT EXPENSE TRANSLATIONAL RESEARCH GRANT 199900 0 0 0 0 0 0 524900 0 524900 EUROPE (INCLUDING ICELAND & GREENLAND) TRANSLATIONAL RESEARCH GRANT 50000 BANK DRAFT 0 NORTH AMERICA (CANADA AND MEXICO, BUT NOT U.S.) DISCOVERY GRANT 200000 BANK DRAFT 0 NORTH AMERICA (CANADA AND MEXICO, BUT NOT U.S.) PSORIATIC DISEASE RESEARCH FELLOWSHIP GRANT 75000 BANK DRAFT 0 EAST ASIA AND THE PACIFIC TRANSLATIONAL RESEARCH GRANT 199900 BANK DRAFT 0 0 4 0 0 0 0 0 0 PART I, LINE 2: GRANT RECIPIENTS WITH MULTI-YEAR AWARDS PROVIDE INTERIM SCIENTIFIC AND PROGRESS REPORTS. ALL GRANT RECIPIENTS PROVIDE A FINAL SCIENTIFIC REPORT AND ACCOUNTING AT THE CONCLUSION OF THE RESEARCH TERM. THE INTERIM AND FINAL REPORTS ARE REVIEWED BY THE RESEARCH DEPARTMENT. PEER TO PEER (TAKE ACTION/TEAM NPF) 741788 741788 17586 26630 13869 13366 49649 COMMIT TO CURE GALA 1522544 1522544 837 104926 54644 20281 93881 6 1107650 1107650 4287 124844 65017 24944 66301 3371982 3371982 22710 256400 133530 58591 209831 681062 -681062 SCHEDULE G, PART II, COLUMN A, EVENT #1 NAME OF EVENT: PEER TO PEER (TAKE ACTION & TEAM NPF) SCHEDULE G, PART II, COLUMN B, EVENT #2 NAME OF EVENT: COMMIT TO CURE GALA SCHEDULE G, PART II, COLUMN C, OTHER EVENTS OTHER COMMUNITY BUILDING EVENTS: 6 1 FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH 11400 ROCKVILLE PIKE SUITE 600 NORTH BETHESDA MD 20852 521986675 501 (C)(3) 100000 0 AMP AIM GRANT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI ONE GUSTAVE L LEVY PLACE NEW YORK NY 10029 136171197 501 (C)(3) 75000 0 DISCOVERY GRANT AWARD NEW YORK UNIVERSITY LANGONE HEALTH 70 WASHINGTON SQUARE SOUTH NEW YORK NY 10012 135562308 501 (C)(3) 100000 0 BRIDGE GRANT REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 1855 FOLSOM STREET STE 425 SAN FRANCISCO CA 941034249 946036493 501 (C)(3) 100000 0 BRIDGE GRANT REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES 595 CHARLES E YOUNG DR E LOS ANGELES CA 90095 956006143 501 (C)(3) 50000 0 PSORIATIC DISEASE RESEARCH FELLOWSHIP GRANT REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO 9500 GILMAN DRIVE LA JOLLA CA 92093 946036493 501 (C)(3) 200000 0 TRANSLATIONAL RESEARCH AWARD THE SCRIPPS RESEARCH INSTITUTE - LA JOLLA 10550 N TORREY PINES ROAD LA JOLLA CA 92037 330435954 501 (C)(3) 50000 0 EARLY CAREER RESEARCH GRANT TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA PO BOX 785541 PHILADELPHIA PA 19178 231352685 501 (C)(3) 838594 0 PPI AWARD TRUSTEES OF PRINCETON UNIVERSITY 619 ALEXANDER ROAD SUITE 102 PRINCETON NJ 08544 210634501 501 (C)(3) 50000 0 EARLY CAREER RESEARCH GRANT UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER 11100 EUCLID AVENUE CLEVELAND OH 44106 340714775 501 (C)(3) 50000 0 PSORIATIC DISEASE RESEARCH FELLOWSHIP GRANT UNIVERSITY OF MICHIGAN MEDICAL CENTER 1500 E MEDICAL CENTER DR ANN ARBOR MI 48109 386006309 501 (C)(3) 50000 0 PSORIATIC DISEASE RESEARCH FELLOWSHIP GRANT VANDERBILT UNIVERSITY MEDICAL CENTER 1211 MEDICAL CENTER DR NASHVILLE TN 37232 352528741 501 (C)(3) 100000 0 BRIDGE GRANT WASHINGTON UNIVERSITY IN ST LOUIS 700 ROSEDALE AVENUE SAINT LOUIS MO 63130 430653611 501 (C)(3) 100000 0 BRIDGE GRANT YALE UNIVERSITY SCHOOL OF MEDICINE 333 CEDAR STREET PO BOX 208059 NEW HAVEN CT 06520 060646973 501 (C)(3) 75000 0 DISCOVERY GRANT AWARD YALE UNIVERSITY SCHOOL OF MEDICINE 333 CEDAR STREET PO BOX 208059 NEW HAVEN CT 06520 060646973 501 (C)(3) 50000 0 EARLY CAREER RESEARCH GRANT 15 0 PART I, LINE 2: GRANT RECIPIENTS WITH MULTI-YEAR AWARDS PROVIDE INTERIM SCIENTIFIC AND FISCAL PROGRESS REPORTS. ALL GRANT RECIPIENTS PROVIDE A FINAL SCIENTIFIC REPORT AND ACCOUNTING AT THE CONCLUSION OF THE RESEARCH TERM. THE INTERIM AND FINAL REPORTS ARE REVIEWED BY THE RESEARCH DEPARTMENT. X X X X 0 1 0 1 0 0 0 0 0 LEAH MCCORMICK HOWARD PRESIDENT/CEO 384224 0 15000 0 0 0 40918 0 2685 0 442827 0 0 0 GUY EAKIN CHIEF SCIENTIFC & MEDICAL OFFICER 251850 0 2500 0 0 0 22632 0 11180 0 288162 0 0 0 JENNIFER FAGERSTROM CHIEF REVENUE OFFICER 231654 0 0 0 0 0 29481 0 17590 0 278725 0 0 0 RONALD GOLDSMAN CHIEF FINANCIAL OFFICER 223895 0 2500 0 0 0 19188 0 1437 0 247020 0 0 0 JENNIFER O'CONNOR VICE PRESIDENT OF ADVANCEMENT 158912 0 1500 0 0 0 8215 0 14706 0 183333 0 0 0 JASON HARRIS VICE PRESIDENT OF GOVERNMENT RELATIO 158156 0 0 0 0 0 8042 0 10165 0 176363 0 0 0 BREANNA BAER VICE PRESIDENT, FIELD DEVELOPMENT & 147803 0 1500 0 0 0 7812 0 17171 0 174286 0 0 0 KATHERINE SOUTHWICK VICE PRESIDENT OF MARKETING & COMMUN 144256 0 0 0 0 0 7308 0 10080 0 161644 0 0 0 PART I, LINE 4B EMPLOYER CONTRIBUTIONS TO 457(B): LEAH MCCORMICK HOWARD - $25,000 JENNIFER FAGERSTOM - $17,500 RONALD GOLDSMAN - $12,500 GUY EAKIN - $10,000 PART I, LINE 5 THE EXECUTIVE TEAM PERFORMANCE-BASED BONUS PORTION OF THE COMPENSATION WAS BASED ON A COMBINATION OF THE EMPLOYEE'S PERFORMANCE AGAINST THEIR INDIVIDUAL OBJECTIVES, THE NPF MEETING ITS ANNUAL REVENUE TARGET AND THE NPF MEETING ITS NET SURPLUS TARGET. X 8 195719 FMV ON DATE RECEIVED 1 0 1 1 PART I, LINE 32B: THE ORGANIZATION ENGAGES WITH OUTSIDE THIRD PARTIES WHEN ACCEPTING REAL ESTATE DONATIONS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS EMAILED TO ALL BOARD MEMBERS FOR THEIR REVIEW PRIOR TO ITS BEING FILED ELECTRONICALLY WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C WE HAVE A CONFLICT OF INTEREST POLICY THAT IS SIGNED BY ALL DIRECTORS ANNUALLY. ALL DIRECTORS AND KEY EMPLOYEES REFRAIN FROM VOTING OR COMMENTING ON ANYTHING WHERE THERE COULD BE A CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF DIRECTORS ANNUALLY REVIEWS AND APPROVES THE CEO'S COMPENSATION. THE FOUNDATION UTILIZES AN INDEPENDENT COMPENSATION CONSULTANT AND SUBSCRIBES TO A SALARY SURVEY FOR COMPARABLE INFORMATION FOR SALARIES. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. AUDITED FINANCIAL STATEMENTS ARE ALSO DISPLAYED ON THE WEBSITE. FORM 990, PART XI, LINE 9: GRANT TURNBACKS NETTED WITH EXPENSES 14,402. LOSS FROM UNCOLLECTIBLES -58,827. CHANGE IN GIFT ANNUITY VALUATION 5,370. FORM 990, PART XII, LINE 2C THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.